LCM
AMAG

Landscape Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Landscape Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-18,922
Closed -$571K – 921
2015
Q4 		$571K Buy
+18,922
New +$611K 0.07% 398
2015
Q3 		– Sell
-9,400
Closed -$649K – 793
2015
Q2 		$649K Sell
9,400
-3,700
-28% -$233K 0.11% 244
2015
Q1 		$716K Buy
+13,100
New +$624K 0.19% 125

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Landscape Capital Management's AMAG Position: Q1 2016 in Review

Landscape Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2016, closing a stake of 18,922 shares — an estimated $571K sold.

Landscape Capital Management first reported a position in AMAG in Q1 2015 and held it in 3 quarters. The position peaked at $716K in Q1 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2016.

  • Landscape Capital Management reported no remaining AMAG Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Landscape Capital Management sold 18,922 AMAG Pharmaceuticals shares in Q1 2016, an estimated $571K.
  • Landscape Capital Management first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Landscape Capital Management's AMAG Pharmaceuticals position peaked at $716K in Q1 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2016.

Based on Landscape Capital Management's 13F filing for Q1 2016, filed 11 May 2016.